Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Preoperative chemoradiation and IOERT for unresectable or borderline resectable pancreas cancer.

Ashman JB, Moss AA, Rule WG, Callister MG, Reddy KS, Mulligan DC, Collins JM, De Petris G, Gunderson LL, Borad M.

J Gastrointest Oncol. 2013 Dec;4(4):352-60. doi: 10.3978/j.issn.2078-6891.2013.006.

PMID:
24294506
[PubMed]
Free PMC Article
2.

Outcomes of minimally invasive esophagectomy in esophageal cancer after neoadjuvant chemoradiotherapy.

Warner S, Chang YH, Paripati H, Ross H, Ashman J, Harold K, Day R, Stucky CC, Rule W, Jaroszewski D.

Ann Thorac Surg. 2014 Feb;97(2):439-45. doi: 10.1016/j.athoracsur.2013.09.042. Epub 2013 Nov 20.

PMID:
24266955
[PubMed - indexed for MEDLINE]
3.

Current status of radiation therapy for the management of rectal cancer.

Rule W, Meyer J.

Crit Rev Oncog. 2012;17(4):331-43. Review.

PMID:
23176041
[PubMed - indexed for MEDLINE]
4.

Rib fracture following stereotactic body radiotherapy: a potential pitfall.

Stanic S, Boike TP, Rule WG, Timmerman RD.

Clin Nucl Med. 2011 Nov;36(11):e168-70. doi: 10.1097/RLU.0b013e318219b539.

PMID:
21975415
[PubMed - indexed for MEDLINE]
5.

Phase I dose-escalation study of stereotactic body radiotherapy in patients with hepatic metastases.

Rule W, Timmerman R, Tong L, Abdulrahman R, Meyer J, Boike T, Schwarz RE, Weatherall P, Chinsoo Cho L.

Ann Surg Oncol. 2011 Apr;18(4):1081-7. doi: 10.1245/s10434-010-1405-5. Epub 2010 Nov 3.

PMID:
21046264
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk